← Leaderboards
Jerome A Dempsey
University Of Wisconsin Madison
$6,412,823
Attributed
$6,412,823
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $778.1K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$6,412,823 · 6
By mechanism
R01$4,792,710 · 2
RC1$810,608 · 1
R21$420,750 · 1
T32$316,755 · 1
R03$72,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Curtis A Smith$3,312,340
- Gerald E Bisgard$1,623,800
Others in their field
Top investigators on “Cardiac Output”
- Angela L. Jefferson · Vanderbilt University Medical Center$24,071,527
- Ziad Nahas · Medical University Of South Carolina$22,722,368
- R Graham Barr · Columbia University Health Sciences$21,152,253
- Bradley E Aouizerat · University Of California, San Francisco$11,913,177
- Phyllis C Tien · University Of California San Francisco$11,913,177
- Mark D Rodefeld · Indiana Univ-Purdue Univ At Indianapolis$10,432,155
Research focus
Cardiac OutputChemoreceptorsRespiratory MusclesHeart FailureExerciseClinical ResearchMotor OutputRespiratoryMuscleRespiratory SystemPreventHuman SubjectTranslatingDogsRespiratorsSleepCardiovascular SystemCanis FamiliarisFatigueDiaphragm (Anatomy)AdrenergicDesignFiberBlood Flow
Grant awards (21)
Use of a Variable Dead Space Rebreathe Device (Smart CO2) to Treat Obstructive and Central Sleep Apnea$191,250
R21 · FY2018 · HL · contact PI
Use of a Variable Dead Space Rebreathe Device (Smart CO2) to Treat Obstructive and Central Sleep Apnea$229,500
R21 · FY2017 · HL · contact PI
Cardiovascular Sequellae of Respiratory Muscle Work$367,500
R01 · FY2011 · HL · contact PI
Targeted Therapies for Selected Phenotypes of Obstructive Sleep Apnea$410,634
RC1 · FY2010 · HL · contact PI
Cardiovascular Sequellae of Respiratory Muscle Work$367,500
R01 · FY2010 · HL · contact PI
Targeted Therapies for Selected Phenotypes of Obstructive Sleep Apnea$399,974
RC1 · FY2009 · HL · contact PI
Cardiovascular Sequellae of Respiratory Muscle Work$367,500
R01 · FY2009 · HL · contact PI
Cardiovascular Sequellae of Respiratory Muscle Work$367,500
R01 · FY2008 · HL · contact PI
Cardiovascular Sequellae of Respiratory Muscle Work$322,978
R01 · FY2007 · HL · contact PI
Cardiovascular Sequellae of Respiratory Muscle Work$319,682
R01 · FY2006 · HL · contact PI
Cardiovascular Sequellae of Respiratory Muscle Work$327,375
R01 · FY2005 · HL
Cardiovascular Sequellae of Respiratory Muscle Work$327,375
R01 · FY2004 · HL
Cardiovascular Sequellae of Respiratory Muscle Work$327,375
R01 · FY2003 · HL
CAUSES OF SLEEP-INDUCED BREATHING INSTABILITIES$400,756
R01 · FY2002 · HL
Cardiovascular Sequellae of Respiratory Muscle Work$327,375
R01 · FY2002 · HL
CAUSES OF SLEEP-INDUCED BREATHING INSTABILITIES$390,840
R01 · FY2001 · HL
PULMONARY PHYSIOLOGY AND PATHOPHYSIOLOGY$77,371
T32 · FY2001 · HL
CAUSES OF SLEEP-INDUCED BREATHING INSTABILITIES$346,303
R01 · FY2000 · HL
PULMONARY PHYSIOLOGY AND PATHOPHYSIOLOGY$239,384
T32 · FY2000 · HL
HUMAN VENTILATORY ADAPTATION$232,651
R01 · FY2000 · HL
SLEEP APNEA IN A NON-CLINICAL POPULATION$72,000
R03 · FY2000 · HL